Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Patent
1995-06-06
1997-08-05
Sidberry, Hazel F.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
4241841, 4241931, 42419711, 536 111, A61K 39106, A61K 3900, A61K 39385, C07H 306
Patent
active
056539860
ABSTRACT:
Substantially pure capsular polysaccharide obtained from Vibrio cholerae Bengal serogroup-O139, capsular polysaccharide-protein conjugates thereof, and antibodies having binding specificity to said capsular polysaccharide.
REFERENCES:
Shimizu et al, "Biological Activities of Lipopolysaccharide Isolated from Vibro cholerae O139, a New Epidemic Strain for Recent Cholera in Indian Subcontinent", Microbiol. Immunol., 38(6):471-474 (1994).
Panigrahi et al, "Human Immune Response to Non-01 Vibrio cholerae Serotype O139", Abstract, 95th General Meeting, Washington, D.C.
Comstock et al, "Cloning of a Region Associated with Capsule and O Antigen Expression of Vibrio cholera Serogroup O139", Abstract, 95th General Meeting, Washington, D.C.
Johnson et al, "Recognition of Pathogenic Strains of Vibrio Cholerae with Restriction Fragments Containing Ribosomal RNA Operon Sequences", Abstract, ASM 1995.
Comstock et al, "The Capsule and O Antigen in Vibrio cholera O139 Bengal Are Associated with a Genetic Region Not Present in Vibrio cholerae O1", Infect. Immun., 63(1):317-323 (1995).
Morris, Jr. et al, "Vibrio cholerae O139 Bengal," In: Vibro Cholea and Cholera, Ed., Wachsmuth et al, AMS Press, Washington, D.C., Chapter 7, pp. 95-102 (1994).
Morris et al, The Journal of Infectious Disease 171:903-8, 1995, Clinical & Immunologic Characteristics in Vibrio cholerae O139 Bengal Infection in N.A. volunteers.
Adams et al The Journ of Clin. Microbiology 19:181-186-1984.
Kabir et al (2) J Med. Microbiol 23:9-18, 1987.
Raziuddin et al Infect & Immun 27:211-215 1980.
Johnson et al Infect & Immunity 60:864-869 1992.
Kabir et al Infect & Immun 38:1263-1272, 1982.
Jann et al Eur J. Biochem 37:531-534, 1973.
Gupta et al Infection & Immun. 60:3201-3208, 1992.
Dick et al. Contribution to Microbiology & Immunology 10:48-114 1989.
Hisatsune et al Biochem Biophys. Res. Com 196:1309-1315, 1993.
Johnson et al, "Non-O1 Vibro cholerae NRT36S Produces a Polysaccharide Capsule That Determines Colony Morphology, Serum Resistance, and Virulence in Mice", Infect. Immun., 60(3):864-869 (Mar., 1992).
Johnson et al, "Characterization of Non-O1 Vibro cholerae Strains from the Bangladesh Epidemic", 33rd Interscience Conference on Antimicrobial Agents and Chemotherapy, Abstract and Poster Presentation, New Orleans, Lousiana (Oct. 17-20, 1993).
Watson et al, "Protection of Mice Against Salmonella typhimurium with an O-Specific Polysaccharide-Protein Conjugate Vaccine", Infect. Immun., 60(11):4679-4686 (Nov., 1992).
Wenger et al, "Efficacy of Haemophilus influenzae Type B Polysaccharide-Diphtheria Toxiod Conjugate Vaccine in US Children aged 18-59 months", The Lancet, 338(8764):395-398 (Aug. 17, 1991).
Johnson et al, "Non-O1 Vibrio cholerae (O39 Synom. Bengal) from the India/Bangladesh Epidemic are Encapsulated", 29th Joint Conference on the U.S.-Japan Cooperative Medical Science Program-Cholera and Related Diahreal Diseases, Monterrey, California (Dec. 1993).
Devi et al, "Antibodies to Poly [(2.fwdarw.8).alpha.-N-acetylneuraminic acid] and Poly [(2.fwdarw.9)-.alpha.-N-acetylneuraminic acid] are Elicited by Immunization of Mice with Escherichia coli K92 Conjugates: Potential Vaccines for Groups B and C Meningococci and E. coli K1", Proc. Natl. Acad. Sci. USA, 88:7175-7179 (Aug., 1991).
Bush C. Allen
Johnson Judith A.
Morris, Jr. J. Glenn
Sidberry Hazel F.
University of Maryland at Baltimore
LandOfFree
Vibrio cholerae bengal serogroup-O139 capsular polysaccharide an does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Vibrio cholerae bengal serogroup-O139 capsular polysaccharide an, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Vibrio cholerae bengal serogroup-O139 capsular polysaccharide an will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1072967